Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 7.07636977 |
2 | axon ensheathment in central nervous system (GO:0032291) | 7.07636977 |
3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.39032390 |
4 | cellular potassium ion homeostasis (GO:0030007) | 6.03385570 |
5 | synaptic vesicle maturation (GO:0016188) | 5.91812362 |
6 | sodium ion export (GO:0071436) | 5.68731480 |
7 | glutamate secretion (GO:0014047) | 5.67374997 |
8 | L-amino acid import (GO:0043092) | 5.58070268 |
9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.56431874 |
10 | synaptic vesicle exocytosis (GO:0016079) | 5.07199826 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03798962 |
12 | L-phenylalanine catabolic process (GO:0006559) | 5.03798962 |
13 | amino acid import (GO:0043090) | 4.98054598 |
14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.83436567 |
15 | L-phenylalanine metabolic process (GO:0006558) | 4.83233633 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.83233633 |
17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.82807505 |
18 | neuronal ion channel clustering (GO:0045161) | 4.54377225 |
19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.54277444 |
20 | potassium ion homeostasis (GO:0055075) | 4.52469642 |
21 | postsynaptic membrane organization (GO:0001941) | 4.48499907 |
22 | potassium ion import (GO:0010107) | 4.48439104 |
23 | locomotory exploration behavior (GO:0035641) | 4.27970659 |
24 | neuronal action potential propagation (GO:0019227) | 4.25494326 |
25 | regulation of synaptic vesicle transport (GO:1902803) | 4.22842814 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 4.21124014 |
27 | lysine metabolic process (GO:0006553) | 4.20894463 |
28 | lysine catabolic process (GO:0006554) | 4.20894463 |
29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.19728389 |
30 | cell communication by electrical coupling (GO:0010644) | 4.12317474 |
31 | neurotransmitter secretion (GO:0007269) | 4.07572007 |
32 | cerebellar granule cell differentiation (GO:0021707) | 4.04037000 |
33 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.03981847 |
34 | alpha-linolenic acid metabolic process (GO:0036109) | 3.99328297 |
35 | neurotransmitter uptake (GO:0001504) | 3.98105631 |
36 | vocalization behavior (GO:0071625) | 3.95963041 |
37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.93092976 |
38 | presynaptic membrane organization (GO:0097090) | 3.90034201 |
39 | astrocyte development (GO:0014002) | 3.86169344 |
40 | cysteine metabolic process (GO:0006534) | 3.81028275 |
41 | aspartate family amino acid catabolic process (GO:0009068) | 3.79453598 |
42 | presynaptic membrane assembly (GO:0097105) | 3.78782271 |
43 | glyoxylate metabolic process (GO:0046487) | 3.77066280 |
44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.71656384 |
45 | cellular sodium ion homeostasis (GO:0006883) | 3.68237753 |
46 | cellular ketone body metabolic process (GO:0046950) | 3.66122974 |
47 | neuron cell-cell adhesion (GO:0007158) | 3.65407924 |
48 | kynurenine metabolic process (GO:0070189) | 3.64602285 |
49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.63583752 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 3.63048181 |
51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.62450239 |
52 | glutamate metabolic process (GO:0006536) | 3.60839340 |
53 | bile acid biosynthetic process (GO:0006699) | 3.58933036 |
54 | acidic amino acid transport (GO:0015800) | 3.56802308 |
55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.53715747 |
56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.52656394 |
57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.51111384 |
58 | exploration behavior (GO:0035640) | 3.51044987 |
59 | synaptic transmission, glutamatergic (GO:0035249) | 3.50973559 |
60 | positive regulation of dendritic spine development (GO:0060999) | 3.49471608 |
61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49310805 |
62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.49134848 |
63 | indole-containing compound catabolic process (GO:0042436) | 3.47093261 |
64 | indolalkylamine catabolic process (GO:0046218) | 3.47093261 |
65 | tryptophan catabolic process (GO:0006569) | 3.47093261 |
66 | positive regulation of synapse maturation (GO:0090129) | 3.46566028 |
67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44651748 |
68 | sulfur amino acid catabolic process (GO:0000098) | 3.41355022 |
69 | neurotransmitter transport (GO:0006836) | 3.41294458 |
70 | regulation of synapse structural plasticity (GO:0051823) | 3.38083067 |
71 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.37007525 |
72 | myelination (GO:0042552) | 3.36519814 |
73 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.36405345 |
74 | acetyl-CoA metabolic process (GO:0006084) | 3.36288822 |
75 | coenzyme catabolic process (GO:0009109) | 3.34305685 |
76 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.32729455 |
77 | regulation of synaptic plasticity (GO:0048167) | 3.32408614 |
78 | neuromuscular process controlling balance (GO:0050885) | 3.32340171 |
79 | axon ensheathment (GO:0008366) | 3.30610015 |
80 | ensheathment of neurons (GO:0007272) | 3.30610015 |
81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.24274492 |
82 | myelin maintenance (GO:0043217) | 3.23986867 |
83 | tryptophan metabolic process (GO:0006568) | 3.23280179 |
84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22688635 |
85 | L-glutamate transport (GO:0015813) | 3.22233926 |
86 | gamma-aminobutyric acid transport (GO:0015812) | 3.22199327 |
87 | long-term synaptic potentiation (GO:0060291) | 3.19699451 |
88 | astrocyte differentiation (GO:0048708) | 3.19463190 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 3.18923707 |
90 | ethanol oxidation (GO:0006069) | 3.18890373 |
91 | alpha-amino acid catabolic process (GO:1901606) | 3.18455510 |
92 | fatty acid beta-oxidation (GO:0006635) | 3.18166560 |
93 | dicarboxylic acid catabolic process (GO:0043649) | 3.18147507 |
94 | glutamate receptor signaling pathway (GO:0007215) | 3.18048910 |
95 | amino-acid betaine metabolic process (GO:0006577) | 3.17706305 |
96 | regulation of neurotransmitter secretion (GO:0046928) | 3.16351347 |
97 | ketone body metabolic process (GO:1902224) | 3.15968082 |
98 | regulation of neurotransmitter levels (GO:0001505) | 3.15833232 |
99 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13729532 |
100 | cellular amino acid catabolic process (GO:0009063) | 3.13270792 |
101 | auditory behavior (GO:0031223) | 3.13041521 |
102 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12099302 |
103 | neuron-neuron synaptic transmission (GO:0007270) | 3.11992098 |
104 | regulation of neurotransmitter transport (GO:0051588) | 3.11334665 |
105 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.11291943 |
106 | protein localization to synapse (GO:0035418) | 3.10960863 |
107 | neurofilament cytoskeleton organization (GO:0060052) | 3.10498499 |
108 | drug catabolic process (GO:0042737) | 3.10181273 |
109 | positive regulation of membrane potential (GO:0045838) | 3.09964792 |
110 | homocysteine metabolic process (GO:0050667) | 3.08941322 |
111 | regulation of dendritic spine development (GO:0060998) | 3.08015589 |
112 | regulation of cell communication by electrical coupling (GO:0010649) | 3.07321962 |
113 | fatty acid oxidation (GO:0019395) | 3.06889845 |
114 | lipid oxidation (GO:0034440) | 3.06507813 |
115 | drug transmembrane transport (GO:0006855) | 3.06381817 |
116 | fatty acid catabolic process (GO:0009062) | 3.04454118 |
117 | aromatic amino acid family metabolic process (GO:0009072) | 3.02061402 |
118 | regulation of ARF protein signal transduction (GO:0032012) | 3.02048297 |
119 | membrane assembly (GO:0071709) | 3.00019616 |
120 | bile acid metabolic process (GO:0008206) | 2.99460089 |
121 | monocarboxylic acid catabolic process (GO:0072329) | 2.99301068 |
122 | detection of calcium ion (GO:0005513) | 2.99178485 |
123 | serine family amino acid catabolic process (GO:0009071) | 2.99095737 |
124 | very long-chain fatty acid metabolic process (GO:0000038) | 2.98161427 |
125 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.96571249 |
126 | synaptic vesicle endocytosis (GO:0048488) | 2.95582613 |
127 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.95351327 |
128 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93580531 |
129 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92738288 |
130 | membrane depolarization during action potential (GO:0086010) | 2.92525222 |
131 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.92118598 |
132 | branched-chain amino acid catabolic process (GO:0009083) | 2.90348585 |
133 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.90014013 |
134 | protein carboxylation (GO:0018214) | 2.87823300 |
135 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.87823300 |
136 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.87669620 |
137 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.87498633 |
138 | tyrosine metabolic process (GO:0006570) | 2.87382917 |
139 | organic acid catabolic process (GO:0016054) | 2.87241034 |
140 | carboxylic acid catabolic process (GO:0046395) | 2.87241034 |
141 | regulation of triglyceride catabolic process (GO:0010896) | 2.87048618 |
142 | exogenous drug catabolic process (GO:0042738) | 2.86555682 |
143 | regulation of postsynaptic membrane potential (GO:0060078) | 2.86223686 |
144 | urea cycle (GO:0000050) | 2.86014655 |
145 | urea metabolic process (GO:0019627) | 2.86014655 |
146 | dendritic spine morphogenesis (GO:0060997) | 2.84141865 |
147 | fatty acid transmembrane transport (GO:1902001) | 2.83927097 |
148 | transmission of nerve impulse (GO:0019226) | 2.82334272 |
149 | regulation of protein activation cascade (GO:2000257) | 2.82167060 |
150 | complement activation, alternative pathway (GO:0006957) | 2.81671310 |
151 | response to mercury ion (GO:0046689) | 2.79781907 |
152 | response to gravity (GO:0009629) | 2.79532072 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.79113781 |
154 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.78457302 |
155 | substantia nigra development (GO:0021762) | 2.78038880 |
156 | long-term memory (GO:0007616) | 2.77904129 |
157 | regulation of synapse maturation (GO:0090128) | 2.77229733 |
158 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.77004400 |
159 | negative regulation of fibrinolysis (GO:0051918) | 2.76881505 |
160 | macromolecular complex remodeling (GO:0034367) | 2.76806199 |
161 | plasma lipoprotein particle remodeling (GO:0034369) | 2.76806199 |
162 | protein-lipid complex remodeling (GO:0034368) | 2.76806199 |
163 | regulation of synaptic transmission (GO:0050804) | 2.76721297 |
164 | positive regulation of dendrite development (GO:1900006) | 2.76717626 |
165 | regulation of neurotransmitter uptake (GO:0051580) | 2.76687412 |
166 | reverse cholesterol transport (GO:0043691) | 2.75870949 |
167 | acyl-CoA biosynthetic process (GO:0071616) | 2.75540217 |
168 | thioester biosynthetic process (GO:0035384) | 2.75540217 |
169 | branched-chain amino acid metabolic process (GO:0009081) | 2.73919052 |
170 | fatty acid elongation (GO:0030497) | 2.72783521 |
171 | valine metabolic process (GO:0006573) | 2.70814972 |
172 | carnitine shuttle (GO:0006853) | 2.70112505 |
173 | thioester metabolic process (GO:0035383) | 2.69606077 |
174 | acyl-CoA metabolic process (GO:0006637) | 2.69606077 |
175 | nitrogen cycle metabolic process (GO:0071941) | 2.69334505 |
176 | regulation of fibrinolysis (GO:0051917) | 2.68376293 |
177 | regulation of complement activation (GO:0030449) | 2.67202094 |
178 | phosphate ion transmembrane transport (GO:0035435) | 2.66207579 |
179 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.66011926 |
180 | carnitine metabolic process (GO:0009437) | 2.64838313 |
181 | urate metabolic process (GO:0046415) | 2.62283113 |
182 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.62078089 |
183 | biotin metabolic process (GO:0006768) | 2.61124607 |
184 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.59371220 |
185 | regulation of cholesterol homeostasis (GO:2000188) | 2.59340051 |
186 | benzene-containing compound metabolic process (GO:0042537) | 2.57992062 |
187 | low-density lipoprotein particle remodeling (GO:0034374) | 2.55444682 |
188 | acylglycerol homeostasis (GO:0055090) | 2.54881746 |
189 | triglyceride homeostasis (GO:0070328) | 2.54881746 |
190 | succinate metabolic process (GO:0006105) | 2.54694396 |
191 | response to methylmercury (GO:0051597) | 2.53642089 |
192 | positive regulation of lipid catabolic process (GO:0050996) | 2.51465317 |
193 | negative regulation of protein activation cascade (GO:2000258) | 2.51080280 |
194 | negative regulation of sterol transport (GO:0032372) | 2.48410989 |
195 | negative regulation of cholesterol transport (GO:0032375) | 2.48410989 |
196 | cholesterol efflux (GO:0033344) | 2.46368714 |
197 | cell communication involved in cardiac conduction (GO:0086065) | 2.46069952 |
198 | small molecule catabolic process (GO:0044282) | 2.45986815 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.57093028 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91691907 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.56764928 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25951658 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.17579598 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.73160366 |
7 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32616171 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.26466516 |
9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13012574 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.99773912 |
11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.99400860 |
12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.94736815 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.83025686 |
14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82115661 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80893422 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75702295 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74809734 |
18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.73956716 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63854457 |
20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62119004 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62119004 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59557857 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55634275 |
24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.54786427 |
25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49360267 |
26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48228374 |
27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47960440 |
28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47847566 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42115564 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41564015 |
31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41458839 |
32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.41431567 |
33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38825982 |
34 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.37452374 |
35 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.37424247 |
36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36880993 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35808958 |
38 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35649192 |
39 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35451312 |
40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35078513 |
41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33133756 |
42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32509423 |
43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32096636 |
44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29193328 |
45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28210223 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27836979 |
47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26435280 |
48 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25520043 |
49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22821861 |
50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22818656 |
51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21424091 |
52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20958372 |
53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20354113 |
54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20354113 |
55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20348807 |
56 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19101126 |
57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18990257 |
58 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.18059329 |
59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17801385 |
60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17367721 |
61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16649412 |
62 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15748779 |
63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13231207 |
64 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12768845 |
65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12178006 |
66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10937129 |
67 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08224844 |
68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07692626 |
69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07325231 |
70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.06886288 |
71 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06156764 |
72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05774762 |
73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04970493 |
74 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04709399 |
75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04646713 |
76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04313878 |
77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03888528 |
78 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03669420 |
79 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03437827 |
80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02820367 |
81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02232492 |
82 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01929987 |
83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01165964 |
84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00962289 |
85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99225305 |
86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99114603 |
87 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.98708556 |
88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98472710 |
89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98426557 |
90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98164591 |
91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97860758 |
92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97489148 |
93 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97345384 |
94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95141626 |
95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93876452 |
96 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92950475 |
97 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92429063 |
98 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91948565 |
99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91616764 |
100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91489209 |
101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91412448 |
102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90451851 |
103 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89442989 |
104 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89030144 |
105 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88969565 |
106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88190044 |
107 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87535134 |
108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86473693 |
109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86020820 |
110 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84428929 |
111 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84054904 |
112 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81671939 |
113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81640405 |
114 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81635439 |
115 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81635439 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81545726 |
117 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81535258 |
118 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81266084 |
119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81150414 |
120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81061022 |
121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80952552 |
122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80621216 |
123 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80573077 |
124 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80444925 |
125 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79696827 |
126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79309526 |
127 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78768383 |
128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.78633926 |
129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77708833 |
130 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.77442552 |
131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77058362 |
132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.76585568 |
133 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.76524199 |
134 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.76231578 |
135 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74560169 |
136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74296175 |
137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73115879 |
138 | * AR_19668381_ChIP-Seq_PC3_Human | 0.72988735 |
139 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72921505 |
140 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72811380 |
141 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72807404 |
142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72769668 |
143 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.70292199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.29807885 |
2 | MP0005360_urolithiasis | 4.92213035 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.98765373 |
4 | MP0005423_abnormal_somatic_nervous | 3.83268633 |
5 | MP0005365_abnormal_bile_salt | 3.55474176 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.49592445 |
7 | MP0005332_abnormal_amino_acid | 2.63928957 |
8 | MP0003806_abnormal_nucleotide_metabolis | 2.55977808 |
9 | MP0005083_abnormal_biliary_tract | 2.43865544 |
10 | MP0003195_calcinosis | 2.31458554 |
11 | MP0010329_abnormal_lipoprotein_level | 2.30959476 |
12 | MP0002735_abnormal_chemical_nociception | 2.21884915 |
13 | MP0003252_abnormal_bile_duct | 2.16559425 |
14 | MP0003329_amyloid_beta_deposits | 2.12170926 |
15 | MP0004043_abnormal_pH_regulation | 2.09019715 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.03323389 |
17 | MP0004270_analgesia | 2.02694016 |
18 | MP0009840_abnormal_foam_cell | 2.02049731 |
19 | MP0004858_abnormal_nervous_system | 1.96684793 |
20 | MP0001984_abnormal_olfaction | 1.91552678 |
21 | MP0003879_abnormal_hair_cell | 1.85679950 |
22 | MP0002118_abnormal_lipid_homeostasis | 1.74347491 |
23 | MP0000778_abnormal_nervous_system | 1.73567775 |
24 | MP0001968_abnormal_touch/_nociception | 1.72731764 |
25 | MP0003690_abnormal_glial_cell | 1.69109512 |
26 | MP0004130_abnormal_muscle_cell | 1.60585530 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.58949869 |
28 | MP0002822_catalepsy | 1.56613461 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.56235928 |
30 | MP0001905_abnormal_dopamine_level | 1.52925161 |
31 | MP0002736_abnormal_nociception_after | 1.52512651 |
32 | MP0001502_abnormal_circadian_rhythm | 1.52033815 |
33 | MP0004811_abnormal_neuron_physiology | 1.48296835 |
34 | MP0001177_atelectasis | 1.48241683 |
35 | MP0005646_abnormal_pituitary_gland | 1.45683811 |
36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45567404 |
37 | MP0000604_amyloidosis | 1.44731533 |
38 | MP0003632_abnormal_nervous_system | 1.44505464 |
39 | MP0006276_abnormal_autonomic_nervous | 1.44333862 |
40 | MP0004859_abnormal_synaptic_plasticity | 1.43994708 |
41 | MP0002733_abnormal_thermal_nociception | 1.43864880 |
42 | MP0009046_muscle_twitch | 1.43284311 |
43 | MP0002066_abnormal_motor_capabilities/c | 1.42826325 |
44 | MP0002734_abnormal_mechanical_nocicepti | 1.41305256 |
45 | MP0002272_abnormal_nervous_system | 1.38417100 |
46 | MP0000751_myopathy | 1.36818176 |
47 | MP0002882_abnormal_neuron_morphology | 1.36586877 |
48 | MP0000955_abnormal_spinal_cord | 1.35920059 |
49 | MP0001666_abnormal_nutrient_absorption | 1.34892418 |
50 | MP0002557_abnormal_social/conspecific_i | 1.33958256 |
51 | MP0004147_increased_porphyrin_level | 1.33777495 |
52 | MP0000920_abnormal_myelination | 1.32502095 |
53 | MP0004036_abnormal_muscle_relaxation | 1.30311392 |
54 | MP0009643_abnormal_urine_homeostasis | 1.28514751 |
55 | MP0003646_muscle_fatigue | 1.26434971 |
56 | MP0001299_abnormal_eye_distance/ | 1.26263394 |
57 | MP0003633_abnormal_nervous_system | 1.23736446 |
58 | MP0003075_altered_response_to | 1.22197007 |
59 | MP0005535_abnormal_body_temperature | 1.22026938 |
60 | MP0003656_abnormal_erythrocyte_physiolo | 1.21670046 |
61 | MP0002064_seizures | 1.21640858 |
62 | MP0003635_abnormal_synaptic_transmissio | 1.20758279 |
63 | MP0001970_abnormal_pain_threshold | 1.19731496 |
64 | MP0004215_abnormal_myocardial_fiber | 1.18122550 |
65 | MP0004885_abnormal_endolymph | 1.15208944 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 1.13899562 |
67 | MP0001958_emphysema | 1.13304561 |
68 | MP0009745_abnormal_behavioral_response | 1.12794281 |
69 | MP0005319_abnormal_enzyme/_coenzyme | 1.12610531 |
70 | MP0002138_abnormal_hepatobiliary_system | 1.11824801 |
71 | MP0000609_abnormal_liver_physiology | 1.09821988 |
72 | MP0001963_abnormal_hearing_physiology | 1.06523911 |
73 | MP0001756_abnormal_urination | 1.04963597 |
74 | MP0003880_abnormal_central_pattern | 1.04670067 |
75 | MP0005623_abnormal_meninges_morphology | 1.04294965 |
76 | MP0006036_abnormal_mitochondrial_physio | 1.04258952 |
77 | MP0002067_abnormal_sensory_capabilities | 1.02959107 |
78 | MP0000747_muscle_weakness | 1.02453949 |
79 | MP0001486_abnormal_startle_reflex | 1.02198566 |
80 | MP0005551_abnormal_eye_electrophysiolog | 1.02019434 |
81 | MP0002909_abnormal_adrenal_gland | 0.99883485 |
82 | MP0002152_abnormal_brain_morphology | 0.99054988 |
83 | MP0001485_abnormal_pinna_reflex | 0.98611204 |
84 | MP0004084_abnormal_cardiac_muscle | 0.96024655 |
85 | MP0004742_abnormal_vestibular_system | 0.95842823 |
86 | MP0003631_nervous_system_phenotype | 0.95825807 |
87 | MP0000749_muscle_degeneration | 0.94131660 |
88 | MP0001765_abnormal_ion_homeostasis | 0.93280588 |
89 | MP0002229_neurodegeneration | 0.93256355 |
90 | MP0004142_abnormal_muscle_tone | 0.93068399 |
91 | MP0003868_abnormal_feces_composition | 0.90928023 |
92 | MP0001440_abnormal_grooming_behavior | 0.90289718 |
93 | MP0005636_abnormal_mineral_homeostasis | 0.90018254 |
94 | MP0005330_cardiomyopathy | 0.90011410 |
95 | MP0000230_abnormal_systemic_arterial | 0.89675437 |
96 | MP0001529_abnormal_vocalization | 0.88715406 |
97 | MP0002063_abnormal_learning/memory/cond | 0.88706190 |
98 | MP0002972_abnormal_cardiac_muscle | 0.88320697 |
99 | MP0002184_abnormal_innervation | 0.87277677 |
100 | MP0002876_abnormal_thyroid_physiology | 0.87250651 |
101 | MP0008569_lethality_at_weaning | 0.86349424 |
102 | MP0004085_abnormal_heartbeat | 0.85797316 |
103 | MP0000579_abnormal_nail_morphology | 0.85229402 |
104 | MP0005670_abnormal_white_adipose | 0.84402365 |
105 | MP0003137_abnormal_impulse_conducting | 0.83470867 |
106 | MP0008874_decreased_physiological_sensi | 0.82603832 |
107 | MP0008775_abnormal_heart_ventricle | 0.81491475 |
108 | MP0005171_absent_coat_pigmentation | 0.81147996 |
109 | MP0001764_abnormal_homeostasis | 0.80895591 |
110 | MP0003634_abnormal_glial_cell | 0.78722792 |
111 | MP0003186_abnormal_redox_activity | 0.78624876 |
112 | MP0005620_abnormal_muscle_contractility | 0.77685266 |
113 | MP0005666_abnormal_adipose_tissue | 0.76792801 |
114 | MP0010368_abnormal_lymphatic_system | 0.76173552 |
115 | MP0005647_abnormal_sex_gland | 0.76162348 |
116 | MP0002572_abnormal_emotion/affect_behav | 0.75545018 |
117 | MP0001501_abnormal_sleep_pattern | 0.74456432 |
118 | MP0002078_abnormal_glucose_homeostasis | 0.74202510 |
119 | MP0000569_abnormal_digit_pigmentation | 0.72880445 |
120 | MP0005167_abnormal_blood-brain_barrier | 0.72623615 |
121 | MP0004484_altered_response_of | 0.71262465 |
122 | MP0006138_congestive_heart_failure | 0.71169176 |
123 | MP0004924_abnormal_behavior | 0.71003449 |
124 | MP0005386_behavior/neurological_phenoty | 0.71003449 |
125 | MP0003787_abnormal_imprinting | 0.70661495 |
126 | MP0005595_abnormal_vascular_smooth | 0.70557452 |
127 | MP0003045_fibrosis | 0.70184376 |
128 | MP0002971_abnormal_brown_adipose | 0.69255395 |
129 | MP0002269_muscular_atrophy | 0.69107260 |
130 | MP0008872_abnormal_physiological_respon | 0.69086423 |
131 | MP0004145_abnormal_muscle_electrophysio | 0.68259462 |
132 | MP0003279_aneurysm | 0.66614751 |
133 | MP0005388_respiratory_system_phenotype | 0.65262422 |
134 | MP0002133_abnormal_respiratory_system | 0.65262422 |
135 | MP0002295_abnormal_pulmonary_circulatio | 0.65257381 |
136 | MP0002752_abnormal_somatic_nervous | 0.65135121 |
137 | MP0001348_abnormal_lacrimal_gland | 0.64134696 |
138 | MP0001346_abnormal_lacrimal_gland | 0.63307066 |
139 | MP0002638_abnormal_pupillary_reflex | 0.59468707 |
140 | MP0002069_abnormal_eating/drinking_beha | 0.58373247 |
141 | MP0005165_increased_susceptibility_to | 0.57962023 |
142 | MP0003705_abnormal_hypodermis_morpholog | 0.56864833 |
143 | MP0003950_abnormal_plasma_membrane | 0.56560223 |
144 | MP0004510_myositis | 0.56513330 |
145 | MP0000026_abnormal_inner_ear | 0.55760878 |
146 | MP0005166_decreased_susceptibility_to | 0.55328997 |
147 | MP0001986_abnormal_taste_sensitivity | 0.53736456 |
148 | MP0010386_abnormal_urinary_bladder | 0.53284491 |
149 | MP0010769_abnormal_survival | 0.51908364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal seizures (HP:0007359) | 4.87231907 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.63296879 |
3 | Abnormality of binocular vision (HP:0011514) | 4.59296864 |
4 | Diplopia (HP:0000651) | 4.59296864 |
5 | Atonic seizures (HP:0010819) | 4.33163540 |
6 | Deep venous thrombosis (HP:0002625) | 4.22110643 |
7 | Febrile seizures (HP:0002373) | 4.17688092 |
8 | Ankle clonus (HP:0011448) | 4.02645253 |
9 | Xanthomatosis (HP:0000991) | 3.95534623 |
10 | Intrahepatic cholestasis (HP:0001406) | 3.95523195 |
11 | Epileptic encephalopathy (HP:0200134) | 3.92858134 |
12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71778322 |
13 | Abnormality of glycine metabolism (HP:0010895) | 3.71778322 |
14 | Hyperglycinuria (HP:0003108) | 3.70416134 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.70335507 |
16 | Ketosis (HP:0001946) | 3.68382811 |
17 | Hyperammonemia (HP:0001987) | 3.66760369 |
18 | Hemiplegia (HP:0002301) | 3.65977497 |
19 | Spastic gait (HP:0002064) | 3.51473717 |
20 | Hyperglycinemia (HP:0002154) | 3.51342763 |
21 | Abnormal eating behavior (HP:0100738) | 3.46674013 |
22 | Gout (HP:0001997) | 3.38494445 |
23 | Ketoacidosis (HP:0001993) | 3.37691874 |
24 | Peripheral hypomyelination (HP:0007182) | 3.36495205 |
25 | Generalized tonic-clonic seizures (HP:0002069) | 3.33745091 |
26 | Obstructive sleep apnea (HP:0002870) | 3.31719112 |
27 | Dysmetria (HP:0001310) | 3.28033819 |
28 | Hemiparesis (HP:0001269) | 3.25120701 |
29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24782138 |
30 | Myokymia (HP:0002411) | 3.20386107 |
31 | Bundle branch block (HP:0011710) | 3.18080050 |
32 | Papilledema (HP:0001085) | 3.15189565 |
33 | Pheochromocytoma (HP:0002666) | 3.08618907 |
34 | Action tremor (HP:0002345) | 3.07134061 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04781002 |
36 | Truncal ataxia (HP:0002078) | 3.04441986 |
37 | Prolonged partial thromboplastin time (HP:0003645) | 2.97575150 |
38 | Absence seizures (HP:0002121) | 2.95573256 |
39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.94729368 |
40 | Hypoglycemic coma (HP:0001325) | 2.94433054 |
41 | Ulnar claw (HP:0001178) | 2.90576492 |
42 | Lower limb muscle weakness (HP:0007340) | 2.89299032 |
43 | Progressive cerebellar ataxia (HP:0002073) | 2.88639322 |
44 | Complement deficiency (HP:0004431) | 2.83283955 |
45 | Dialeptic seizures (HP:0011146) | 2.79800491 |
46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.79629722 |
47 | Termporal pattern (HP:0011008) | 2.77428769 |
48 | Insidious onset (HP:0003587) | 2.77428769 |
49 | Torticollis (HP:0000473) | 2.76986503 |
50 | Tetraplegia (HP:0002445) | 2.75662072 |
51 | Cerebral hypomyelination (HP:0006808) | 2.75238171 |
52 | Epidermoid cyst (HP:0200040) | 2.70036122 |
53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67547806 |
54 | Neuroendocrine neoplasm (HP:0100634) | 2.66455932 |
55 | Hypoalphalipoproteinemia (HP:0003233) | 2.65544121 |
56 | Dysdiadochokinesis (HP:0002075) | 2.65125695 |
57 | Insomnia (HP:0100785) | 2.64599514 |
58 | Increased circulating renin level (HP:0000848) | 2.64278016 |
59 | Hypokalemic alkalosis (HP:0001949) | 2.64084380 |
60 | Megalencephaly (HP:0001355) | 2.63386765 |
61 | Hypobetalipoproteinemia (HP:0003563) | 2.58601703 |
62 | Cerebral hemorrhage (HP:0001342) | 2.55281303 |
63 | Neurofibrillary tangles (HP:0002185) | 2.53109116 |
64 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48656910 |
65 | Visual hallucinations (HP:0002367) | 2.47930017 |
66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.45583643 |
67 | Urinary urgency (HP:0000012) | 2.45338134 |
68 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.44538166 |
69 | Aplasia of the phalanges of the hand (HP:0009802) | 2.44538166 |
70 | Aplasia involving bones of the extremities (HP:0009825) | 2.44538166 |
71 | Delayed CNS myelination (HP:0002188) | 2.43735926 |
72 | Hypolipoproteinemia (HP:0010981) | 2.42303733 |
73 | Heart block (HP:0012722) | 2.40338258 |
74 | Metabolic acidosis (HP:0001942) | 2.38215680 |
75 | Clonus (HP:0002169) | 2.37626830 |
76 | Limb dystonia (HP:0002451) | 2.36367327 |
77 | Abnormality of purine metabolism (HP:0004352) | 2.35458611 |
78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34999286 |
79 | Dicarboxylic aciduria (HP:0003215) | 2.34999286 |
80 | Spastic tetraparesis (HP:0001285) | 2.34754849 |
81 | Mutism (HP:0002300) | 2.34693861 |
82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33581582 |
83 | Hyporeflexia of lower limbs (HP:0002600) | 2.33067469 |
84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32901744 |
85 | Abnormality of methionine metabolism (HP:0010901) | 2.32611103 |
86 | Alacrima (HP:0000522) | 2.32219837 |
87 | Alkalosis (HP:0001948) | 2.29747093 |
88 | Abnormal atrioventricular conduction (HP:0005150) | 2.29549007 |
89 | Supranuclear gaze palsy (HP:0000605) | 2.29225006 |
90 | Split foot (HP:0001839) | 2.27867500 |
91 | Annular pancreas (HP:0001734) | 2.26277497 |
92 | Depression (HP:0000716) | 2.25743722 |
93 | Metabolic alkalosis (HP:0200114) | 2.25292074 |
94 | Potter facies (HP:0002009) | 2.24375254 |
95 | Facial shape deformation (HP:0011334) | 2.24375254 |
96 | Anxiety (HP:0000739) | 2.23838506 |
97 | Cerebral edema (HP:0002181) | 2.22189981 |
98 | Lethargy (HP:0001254) | 2.22088490 |
99 | Hyperuricemia (HP:0002149) | 2.21930771 |
100 | Increased purine levels (HP:0004368) | 2.21930771 |
101 | Onion bulb formation (HP:0003383) | 2.21546224 |
102 | Rigidity (HP:0002063) | 2.19899243 |
103 | Hypomagnesemia (HP:0002917) | 2.18660700 |
104 | Focal motor seizures (HP:0011153) | 2.18616196 |
105 | Neuronal loss in central nervous system (HP:0002529) | 2.17791445 |
106 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17275851 |
107 | Myoglobinuria (HP:0002913) | 2.15645213 |
108 | Turricephaly (HP:0000262) | 2.14664629 |
109 | Focal dystonia (HP:0004373) | 2.13817031 |
110 | Akinesia (HP:0002304) | 2.13814849 |
111 | Delusions (HP:0000746) | 2.13340248 |
112 | Fat malabsorption (HP:0002630) | 2.13092283 |
113 | Sensorimotor neuropathy (HP:0007141) | 2.13085489 |
114 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12342290 |
115 | Abnormality of serum amino acid levels (HP:0003112) | 2.12082432 |
116 | Bradykinesia (HP:0002067) | 2.11706306 |
117 | Hyperactive renin-angiotensin system (HP:0000841) | 2.11323715 |
118 | Sleep apnea (HP:0010535) | 2.11190238 |
119 | Rapidly progressive (HP:0003678) | 2.09648438 |
120 | Vascular calcification (HP:0004934) | 2.04808025 |
121 | Scanning speech (HP:0002168) | 2.04558246 |
122 | Hammertoe (HP:0001765) | 2.04474997 |
123 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.04280174 |
124 | Neonatal onset (HP:0003623) | 2.04057709 |
125 | Craniofacial dystonia (HP:0012179) | 2.03096181 |
126 | Joint hemorrhage (HP:0005261) | 2.01356309 |
127 | Status epilepticus (HP:0002133) | 2.01137358 |
128 | Epileptiform EEG discharges (HP:0011182) | 2.01019269 |
129 | Abnormality of the lower motor neuron (HP:0002366) | 2.00916065 |
130 | Cerebral inclusion bodies (HP:0100314) | 1.99358173 |
131 | Atrial fibrillation (HP:0005110) | 1.99121604 |
132 | Foot dorsiflexor weakness (HP:0009027) | 1.98652677 |
133 | Abnormality of the corticospinal tract (HP:0002492) | 1.96462562 |
134 | Vomiting (HP:0002013) | 1.96212006 |
135 | Atrioventricular block (HP:0001678) | 1.96187937 |
136 | Shallow orbits (HP:0000586) | 1.95890812 |
137 | Abnormal gallbladder morphology (HP:0012437) | 1.95404900 |
138 | Apathy (HP:0000741) | 1.95304200 |
139 | Cholelithiasis (HP:0001081) | 1.93083555 |
140 | Skin nodule (HP:0200036) | 1.92140442 |
141 | Poor eye contact (HP:0000817) | 1.92116123 |
142 | Axonal loss (HP:0003447) | 1.91924047 |
143 | Intention tremor (HP:0002080) | 1.91125971 |
144 | Proximal tubulopathy (HP:0000114) | 1.90822774 |
145 | Primary atrial arrhythmia (HP:0001692) | 1.90270716 |
146 | Decreased motor nerve conduction velocity (HP:0003431) | 1.90081766 |
147 | Sudden death (HP:0001699) | 1.90069380 |
148 | Bronchomalacia (HP:0002780) | 1.87878384 |
149 | Ventricular fibrillation (HP:0001663) | 1.87818173 |
150 | Prolonged QT interval (HP:0001657) | 1.87705193 |
151 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86382975 |
152 | Choreoathetosis (HP:0001266) | 1.85444553 |
153 | Irritability (HP:0000737) | 1.84405873 |
154 | Hyperbilirubinemia (HP:0002904) | 1.84260321 |
155 | Exercise-induced myalgia (HP:0003738) | 1.84192441 |
156 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82779171 |
157 | Muscle fiber splitting (HP:0003555) | 1.82541217 |
158 | Syncope (HP:0001279) | 1.82231948 |
159 | Supraventricular tachycardia (HP:0004755) | 1.80866179 |
160 | Abnormality of the periventricular white matter (HP:0002518) | 1.80703072 |
161 | Slow progression (HP:0003677) | 1.80165289 |
162 | Cardiovascular calcification (HP:0011915) | 1.79951346 |
163 | Decreased lacrimation (HP:0000633) | 1.79427874 |
164 | Lower limb amyotrophy (HP:0007210) | 1.79198902 |
165 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.78834046 |
166 | Supraventricular arrhythmia (HP:0005115) | 1.78178192 |
167 | Amyloidosis (HP:0011034) | 1.77666362 |
168 | Hypercholesterolemia (HP:0003124) | 1.77557429 |
169 | Acute encephalopathy (HP:0006846) | 1.76234472 |
170 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.74751635 |
171 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.74751635 |
172 | Overriding aorta (HP:0002623) | 1.74499955 |
173 | Postural instability (HP:0002172) | 1.74083491 |
174 | Muscle stiffness (HP:0003552) | 1.73565467 |
175 | Conjugated hyperbilirubinemia (HP:0002908) | 1.73033759 |
176 | Hyperaldosteronism (HP:0000859) | 1.72291436 |
177 | Abnormality of the foot musculature (HP:0001436) | 1.72180425 |
178 | Abnormality of the intrinsic pathway (HP:0010989) | 1.71122809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 4.12091740 |
2 | LMTK2 | 3.51702622 |
3 | STK39 | 3.19160528 |
4 | UHMK1 | 3.18438113 |
5 | WNK4 | 2.95217315 |
6 | BCKDK | 2.85988378 |
7 | OXSR1 | 2.61777540 |
8 | NTRK1 | 2.40883246 |
9 | PHKG1 | 2.30213221 |
10 | PHKG2 | 2.30213221 |
11 | NTRK3 | 2.26162896 |
12 | MAP2K4 | 2.07267740 |
13 | PINK1 | 2.07174080 |
14 | WNK1 | 2.00601265 |
15 | MINK1 | 1.98930487 |
16 | SGK223 | 1.88820467 |
17 | SGK494 | 1.88820467 |
18 | CASK | 1.81575099 |
19 | EPHB1 | 1.81064058 |
20 | MAP3K4 | 1.77497949 |
21 | KSR2 | 1.72970945 |
22 | PDK3 | 1.62078029 |
23 | PDK4 | 1.62078029 |
24 | MAP3K9 | 1.60421173 |
25 | PLK2 | 1.57447942 |
26 | WNK3 | 1.51939549 |
27 | TYRO3 | 1.51139956 |
28 | SIK1 | 1.51085394 |
29 | FGFR2 | 1.41322287 |
30 | ARAF | 1.38994813 |
31 | TRIB3 | 1.36136886 |
32 | MAP3K2 | 1.35974854 |
33 | SGK2 | 1.33420169 |
34 | CAMK1 | 1.32527642 |
35 | LATS2 | 1.31755916 |
36 | SGK3 | 1.28927826 |
37 | PAK6 | 1.28511120 |
38 | NEK6 | 1.25486472 |
39 | FGFR4 | 1.23866992 |
40 | PRPF4B | 1.23209262 |
41 | RET | 1.18062455 |
42 | PDK2 | 1.16036731 |
43 | TIE1 | 1.14227950 |
44 | DAPK2 | 1.14028506 |
45 | MAPK13 | 1.08149398 |
46 | STK38 | 1.05334173 |
47 | PDPK1 | 1.01251212 |
48 | PAK3 | 1.00435761 |
49 | FER | 0.98536492 |
50 | CAMK2G | 0.98118777 |
51 | GRK7 | 0.96611479 |
52 | MAPK10 | 0.96403036 |
53 | MAP2K7 | 0.96342154 |
54 | MYLK | 0.94593916 |
55 | PDGFRA | 0.93648742 |
56 | CDK15 | 0.93063568 |
57 | CDK18 | 0.89240256 |
58 | INSRR | 0.88749464 |
59 | MAP3K7 | 0.88314604 |
60 | EPHA4 | 0.87185653 |
61 | MARK2 | 0.86379834 |
62 | DYRK1A | 0.84961626 |
63 | PRKD3 | 0.84943893 |
64 | ERBB4 | 0.82123714 |
65 | GRK5 | 0.82099610 |
66 | CDK11A | 0.81083695 |
67 | PRKD1 | 0.79945721 |
68 | DAPK1 | 0.79688150 |
69 | MUSK | 0.79260443 |
70 | LIMK1 | 0.78606813 |
71 | CDK14 | 0.78091649 |
72 | PRKCH | 0.77551431 |
73 | MAP2K1 | 0.76476337 |
74 | CAMKK1 | 0.76063727 |
75 | DMPK | 0.75817367 |
76 | NEK9 | 0.75127247 |
77 | OBSCN | 0.73768182 |
78 | MAP3K12 | 0.73730098 |
79 | ALK | 0.72501469 |
80 | CDK5 | 0.71301716 |
81 | CAMK2A | 0.68516465 |
82 | PDK1 | 0.67361299 |
83 | CAMK1G | 0.67004062 |
84 | PNCK | 0.66743886 |
85 | MAP3K1 | 0.65927703 |
86 | CAMK2D | 0.64940194 |
87 | NEK1 | 0.63964858 |
88 | MST1R | 0.63323905 |
89 | RPS6KA3 | 0.63170656 |
90 | ERN1 | 0.63085820 |
91 | STK11 | 0.62734330 |
92 | DDR2 | 0.62559761 |
93 | PTK2 | 0.61460312 |
94 | MAPKAPK5 | 0.61319592 |
95 | PRKCG | 0.60654608 |
96 | PKN1 | 0.60646832 |
97 | PRKAA1 | 0.60581575 |
98 | TESK1 | 0.60297504 |
99 | PRKACG | 0.60005723 |
100 | PIK3CA | 0.59801873 |
101 | PRKCE | 0.59231113 |
102 | STK38L | 0.59058502 |
103 | DAPK3 | 0.58698686 |
104 | PRKAA2 | 0.58582054 |
105 | RIPK1 | 0.58414755 |
106 | ROCK2 | 0.57926204 |
107 | MAPK12 | 0.57303250 |
108 | RIPK4 | 0.57150571 |
109 | NTRK2 | 0.56842970 |
110 | PTK2B | 0.55608580 |
111 | CAMK4 | 0.54720161 |
112 | PRKCZ | 0.53070202 |
113 | PRKG1 | 0.52394635 |
114 | ROCK1 | 0.51797375 |
115 | MAPKAPK3 | 0.51651150 |
116 | MET | 0.51042263 |
117 | TNK2 | 0.50752268 |
118 | CAMKK2 | 0.50508357 |
119 | CAMK1D | 0.50140342 |
120 | TTN | 0.49284151 |
121 | PRKACB | 0.48788410 |
122 | KSR1 | 0.48559465 |
123 | MAPK4 | 0.47810918 |
124 | PDGFRB | 0.47781592 |
125 | BMPR2 | 0.47657213 |
126 | SIK2 | 0.47116087 |
127 | FYN | 0.47115356 |
128 | PRKACA | 0.46974072 |
129 | ADRBK1 | 0.46173110 |
130 | TNIK | 0.45541822 |
131 | CAMK2B | 0.44785151 |
132 | EPHA3 | 0.43799475 |
133 | PAK2 | 0.41764707 |
134 | GSK3A | 0.40992398 |
135 | MAPK7 | 0.40728164 |
136 | CSNK1G2 | 0.40232345 |
137 | SGK1 | 0.39540178 |
138 | RAF1 | 0.39327614 |
139 | JAK2 | 0.38806348 |
140 | MOS | 0.38318063 |
141 | PRKCQ | 0.38114924 |
142 | MAP3K13 | 0.36889037 |
143 | BRSK1 | 0.36560523 |
144 | LRRK2 | 0.36313602 |
145 | PRKG2 | 0.36056406 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.32098498 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.82323742 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74997514 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62299118 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58591428 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.56788603 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51068004 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49679267 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48803181 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44926987 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.41991122 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38782703 |
13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.36723800 |
14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16542784 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10005079 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.09559422 |
17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04087610 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.02537944 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00372864 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.81885910 |
21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81634293 |
22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79386539 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.75770333 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73703278 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71228712 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67673589 |
27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66112245 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.65936114 |
29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56833106 |
30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52480331 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.52177348 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50088271 |
33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47884923 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44245441 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43321471 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42694140 |
37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42654731 |
38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30823969 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29201187 |
40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28180769 |
41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27238901 |
42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.22302516 |
43 | Gap junction_Homo sapiens_hsa04540 | 1.20917297 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19725165 |
45 | Long-term depression_Homo sapiens_hsa04730 | 1.19125151 |
46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18941965 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16730865 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15797851 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15261447 |
50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15141403 |
51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14621024 |
52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11026888 |
53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07432183 |
54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07193662 |
55 | Glioma_Homo sapiens_hsa05214 | 1.05032851 |
56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00991761 |
57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99350661 |
58 | Melanogenesis_Homo sapiens_hsa04916 | 0.99125454 |
59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97441023 |
60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95105134 |
61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94556951 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93228441 |
63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93018728 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88889030 |
65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88205343 |
66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86575699 |
67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85876080 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.84952592 |
69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84387344 |
70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83650381 |
71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83211983 |
72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82249125 |
73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80743128 |
74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80610600 |
75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80524304 |
76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79917308 |
77 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79643954 |
78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78677216 |
79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78292850 |
80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76898387 |
81 | Axon guidance_Homo sapiens_hsa04360 | 0.75447750 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75436043 |
83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73801679 |
84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70265923 |
85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70046101 |
86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69788092 |
87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69414497 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68811469 |
89 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.68652787 |
90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68243075 |
91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67556805 |
92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67483156 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67458693 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64151926 |
95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63031515 |
96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61733647 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60586202 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.60572055 |
99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59575570 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58229495 |
101 | Tight junction_Homo sapiens_hsa04530 | 0.57453031 |
102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57076942 |
103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56178194 |
104 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55714533 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54987260 |
106 | Focal adhesion_Homo sapiens_hsa04510 | 0.54579674 |
107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54254909 |
108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53420173 |
109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49668451 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48778969 |
111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47567389 |
112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47433500 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46476381 |
114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45487657 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45155135 |
116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44793675 |
117 | Salivary secretion_Homo sapiens_hsa04970 | 0.44743148 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44388175 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43671178 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43661429 |
121 | Insulin secretion_Homo sapiens_hsa04911 | 0.41812964 |
122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41555291 |
123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41465564 |
124 | Lysine degradation_Homo sapiens_hsa00310 | 0.41121962 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39739417 |
126 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38553746 |
127 | Insulin resistance_Homo sapiens_hsa04931 | 0.38359813 |
128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37843620 |
129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37535026 |
130 | Taste transduction_Homo sapiens_hsa04742 | 0.37524130 |
131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36727048 |
132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34527694 |
133 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.34498820 |
134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34396593 |
135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33398880 |
136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32949127 |
137 | Renin secretion_Homo sapiens_hsa04924 | 0.32700776 |
138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32635788 |
139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32288624 |
140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32221961 |
141 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31070803 |
142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30989712 |
143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.30676102 |
144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30214259 |
145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30156016 |
146 | Amoebiasis_Homo sapiens_hsa05146 | 0.30005362 |
147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29423769 |
148 | Prion diseases_Homo sapiens_hsa05020 | 0.29421129 |
149 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29242175 |
150 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29134277 |
151 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28605726 |
152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26171927 |
153 | Mineral absorption_Homo sapiens_hsa04978 | 0.25842008 |
154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25622999 |
155 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25459705 |
156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25027027 |
157 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24326438 |
158 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24150048 |
159 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23934735 |
160 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23485092 |
161 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21809488 |
162 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.21641623 |